Opioids

FDA

Pharma

Peptide adcomm Day 2: Emideltide fails to make grade in vote

The first peptide to go up against an adcomm vote Friday did not fare as well as those assessed on Day 1 of the meeting.

Fraiser Kansteiner Jul 24, 2026 2:00pm

A chessboard with blocks that read MA

Noramco divests two fill-finish sites as new CDMO Halo Pharma

Jan 27, 2026 10:20am

drug label warning

Fierce Healthcare

FDA requires label changes to opioid pain meds to clarify risks

Aug 1, 2025 11:31am

Indivior Opvee packaging

Indivior-backed paper spotlights rapid opioid reversal meds

Apr 29, 2025 9:30am

merger MA combined company mergers acquisitions business development

Troubled Mallinckrodt, Endo telegraph $6.7B merger plans

Mar 13, 2025 10:18am

Journavx

FDA signs off on Vertex's non-opioid pain reliever Journavx

Jan 30, 2025 9:22pm